ZA906100B - Escherichia coli vaccine - Google Patents

Escherichia coli vaccine

Info

Publication number
ZA906100B
ZA906100B ZA906100A ZA906100A ZA906100B ZA 906100 B ZA906100 B ZA 906100B ZA 906100 A ZA906100 A ZA 906100A ZA 906100 A ZA906100 A ZA 906100A ZA 906100 B ZA906100 B ZA 906100B
Authority
ZA
South Africa
Prior art keywords
escherichia coli
coli vaccine
vaccine
escherichia
coli
Prior art date
Application number
ZA906100A
Other languages
English (en)
Inventor
Johannes Franciscus Van Bosch
Franciscus Van Den Bo Johannes
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA906100B publication Critical patent/ZA906100B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA906100A 1989-08-18 1990-08-02 Escherichia coli vaccine ZA906100B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (1)

Publication Number Publication Date
ZA906100B true ZA906100B (en) 1991-05-29

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906100A ZA906100B (en) 1989-08-18 1990-08-02 Escherichia coli vaccine

Country Status (16)

Country Link
US (1) US5750115A (enExample)
EP (1) EP0413378B1 (enExample)
JP (1) JP3031561B2 (enExample)
KR (1) KR0177510B1 (enExample)
CN (1) CN1062605C (enExample)
AU (1) AU635062B2 (enExample)
CA (1) CA2022420C (enExample)
DE (1) DE69016129T2 (enExample)
DK (1) DK0413378T3 (enExample)
ES (1) ES2070266T3 (enExample)
GR (1) GR3015782T3 (enExample)
HU (2) HU210965B (enExample)
IL (1) IL95175A (enExample)
NZ (1) NZ234933A (enExample)
TW (1) TW204353B (enExample)
ZA (1) ZA906100B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
EP1011440A4 (en) * 1997-05-16 2003-08-06 Medical Defense Tech Llc VACCINE AGAINST THE CORE OF LIPOPOLYSACCHARIDES
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
IL139538A0 (en) * 1998-05-15 2004-02-08 Mkb Invest Ltd Partnership Compositions and method for immunizing poultry
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
BRPI0615593A2 (pt) * 2005-08-30 2011-05-24 Commw Scient And Ind Reseaech Organisation liberação bacteriana de polipeptìdeos biologicamente ativos
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
NZ622456A (en) 2009-10-12 2015-09-25 New Health Sciences Inc Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
EP2389064A4 (en) 2009-10-12 2014-10-01 New Health Sciences Inc OXYGEN DETECTION DEVICES AND METHOD FOR REMOVING OXYGEN FROM RED BLOOD CELLS
EP2608816B1 (en) 2010-08-25 2023-07-05 Hemanext Inc. Method for enhancing red blood cell quality and survival during storage
EP3539381B1 (en) 2010-11-05 2023-05-24 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
ES2576977T3 (es) 2011-08-10 2016-07-12 New Health Sciences, Inc. Empobrecimiento integrado de leucocitos, oxígeno y/o CO2 y dispositivo de filtro de separación de plasma
JP2016517395A (ja) 2013-02-28 2016-06-16 ニュー・ヘルス・サイエンシーズ・インコーポレイテッドＮｅｗ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 血液処理のためのガス枯渇化およびガス添加デバイス
IL299978B2 (en) 2015-03-10 2024-08-01 Hemanext Inc Single-use oxygen reduction kits, devices and methods for their use
AU2016253005B2 (en) 2015-04-23 2020-07-09 Hemanext Inc. Anaerobic blood storage containers
BR122021024410B1 (pt) 2015-05-18 2022-05-03 Hemanext Inc Métodos para gerenciar um banco de sangue e para prover fornecimento de produtos de sangue total armazenados para medicina de transfusão
PT3463466T (pt) 2016-05-27 2022-04-04 Hemanext Inc Método de armazenamento de sangue anaeróbio e inativação de patógenos
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.

Also Published As

Publication number Publication date
DK0413378T3 (da) 1995-05-15
ES2070266T3 (es) 1995-06-01
JP3031561B2 (ja) 2000-04-10
CA2022420C (en) 2000-03-28
KR0177510B1 (ko) 1999-03-20
DE69016129D1 (de) 1995-03-02
CN1062605C (zh) 2001-02-28
KR910004209A (ko) 1991-03-28
NZ234933A (en) 1992-06-25
AU6109990A (en) 1991-02-21
HU210965B (en) 1995-09-28
US5750115A (en) 1998-05-12
HUT59612A (en) 1992-06-29
EP0413378A1 (en) 1991-02-20
HU211827A9 (en) 1995-12-28
AU635062B2 (en) 1993-03-11
CA2022420A1 (en) 1991-02-19
IL95175A (en) 1994-05-30
TW204353B (enExample) 1993-04-21
IL95175A0 (en) 1991-06-10
EP0413378B1 (en) 1995-01-18
HU905053D0 (en) 1991-01-28
DE69016129T2 (de) 1995-05-24
CN1049523A (zh) 1991-02-27
GR3015782T3 (en) 1995-07-31
JPH03184996A (ja) 1991-08-12

Similar Documents

Publication Publication Date Title
IL95175A0 (en) Escherichia coli vaccine
GB9105992D0 (en) Vaccine
GB8924438D0 (en) Vaccine composition
EP0454735A4 (en) Vaccine composition
EP0391997A4 (en) Vaccine
AP9100332A0 (en) Vaccines
GB8921470D0 (en) Vaccines
ZA887694B (en) Vaccine against e.coli septicaemia in poultry
GB8918689D0 (en) 25/15 vaccine
AP9000165A0 (en) Vaccine composition
GB9112310D0 (en) Fish vaccine
GB8704647D0 (en) Vaccine
GB2313179A8 (en) Field howitzers
GB8912496D0 (en) Vaccines
GB8819836D0 (en) Vaccine
EP0453452A4 (en) Vaccine
GB8905748D0 (en) Genetic modification of escherichia coli
GB8922651D0 (en) Vaccine
CS77189A1 (en) Genically recombined bacterial cells escherichia coli
ZA909516B (en) Novel vaccine
IE892784L (en) Vaccines
GB8926832D0 (en) Vaccines
GB8917942D0 (en) Vaccines
GB8919940D0 (en) Vaccines
GB8914532D0 (en) Vaccines